Suchergebnisse - "Sarilumab"

PubPharm (319)

161

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY) : protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial

enthalten in: BMJ open | 2020

von León López, R. | Fernández, S. | Limia Pérez, L. | +11

162

Potential strategies for combating COVID-19

enthalten in: Archives of virology | 2020

von Shamim, S. | Khan, M. | Kharaba, Z. | +2

163

COVID-19 : Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients

enthalten in: Journal of medical virology | 2020

von Chakraborty, C. | Sharma, A. | Bhattacharya, M. | +3

CommentIn: J Med Virol. 2021 Jan;93(1):46-47. - PMID 32484915

164

Sarilumab use in severe SARS-CoV-2 pneumonia

enthalten in: EClinicalMedicine | 2020

von Gremese, E. | Cingolani, A. | Bosello, S. | +39

165

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis research & therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

166

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis Research & Therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

167

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis Research & Therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

168

Emerging treatments in COVID-19 : Adverse drug reactions including drug hypersensitivities

enthalten in: The Journal of allergy and clinical immunology | 2020

von Manjaly Thomas, Z. | Leuppi-Taegtmeyer, A. | Jamiolkowski, D. | +4

169

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

enthalten in: Infection | 2020

von Cingolani, A. | Tummolo, A. | Montemurro, G. | +39

170

Role of monoclonal antibody drugs in the treatment of COVID-19

enthalten in: World journal of clinical cases | 2020

von Ucciferri, C. | Vecchiet, J. | Falasca, K.